1) Salmeterol/fluticasone
沙美特罗/氟替卡松
1.
Effects of inhaled salmeterol/fluticasone combined with respiratory rehabilitation training in senile patients with stable severe chronic obstructive pulmonary disease
吸入沙美特罗/氟替卡松联合呼吸训练治疗Ⅲ、Ⅳ级稳定期COPD老年患者的临床研究
2.
Conclusions Salmeterol/fluticasone can improve asthmatic children\'s pulmonary function significantly,control asthmatic symptoms of day and night,reduce the dosis of β2 adrenoceptor agonist and the ratio of emergency treatment and in hospital times,increase the patient\'s quality of life,haven\'t apparente side effects,is an ideal medicine to cure asthma currently.
目的观察支气管哮喘(简称哮喘)儿童吸入沙美特罗/氟替卡松(商品名舒利迭)治疗儿童哮喘的临床疗效与骨密度变化。
3) Salmeterol/fluticasone propionate
沙美特罗替卡松
1.
Lung function and safety of children with moderate-severe asthma treated by salmeterol/fluticasone propionate;
沙美特罗替卡松治疗儿童中重度哮喘的肺功能及安全性观察
4) Salmeterol/Fluticasone
沙美特罗替卡松
1.
The Improvement of Salmeterol/Fluticasone on Inspiratory Capacity in Patients with Stable Chronic Obstructive Pulmonary Disease;
沙美特罗替卡松对稳定期COPD患者深吸气量的改善作用
2.
Salmeterol/Fluticasone Powder Inhalation for Patients with Cough-Variant Asthma: Clinical Observation on 43 Cases;
沙美特罗替卡松粉吸入剂治疗咳嗽变异型哮喘43例临床观察
5) salmeterol/flutieasone propionate
沙美特罗/氟替卡松(舒利迭)
6) Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation
沙美特罗氟替卡松粉吸入剂
1.
Nursing Intervention on Using Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation in COPD Patients;
慢性阻塞性肺疾病患者使用沙美特罗氟替卡松粉吸入剂的护理干预
补充资料:β-美松
分子式:C22H29FO5
分子量:392.45
CAS号:378-44-9
性质:白色结晶性粉末。熔点231-234℃(分解)。无臭。醋酸倍他米松([987-24-6])亦为白色结晶性粉末,熔点205-208℃,微溶于丙醇、乙醇,极难溶于氯仿或乙醚,不溶于水,无臭。
制备方法:按美国专利3164618,将醋酸倍他米松于甲醇-氯仿-水的混合物中以盐酸处理,可使其转换为倍他米松。
用途:激素类药。主要用于抗炎及抗过敏。适用于风湿性关节炎及各种皮肤病。倍他米松的作用同地塞米松,其抗炎作用比地塞米松、去炎松、氢化可的松强,副作用少。
分子量:392.45
CAS号:378-44-9
性质:白色结晶性粉末。熔点231-234℃(分解)。无臭。醋酸倍他米松([987-24-6])亦为白色结晶性粉末,熔点205-208℃,微溶于丙醇、乙醇,极难溶于氯仿或乙醚,不溶于水,无臭。
制备方法:按美国专利3164618,将醋酸倍他米松于甲醇-氯仿-水的混合物中以盐酸处理,可使其转换为倍他米松。
用途:激素类药。主要用于抗炎及抗过敏。适用于风湿性关节炎及各种皮肤病。倍他米松的作用同地塞米松,其抗炎作用比地塞米松、去炎松、氢化可的松强,副作用少。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条